Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutramont is a Swiss-based healthcare company specializing in the research, development, and commercialization of advanced clinical nutrition products and medical foods. The company focuses on the "Food for Special Medical Purposes" (FSMP) category, providing targeted nutritional interventions for patients with chronic and complex conditions. Its portfolio primarily addresses the metabolic needs of individuals suffering from chronic kidney disease, oncology-related malnutrition, and various metabolic disorders. By utilizing high-quality amino acid profiles and specialized nutrient formulations, Nutramont aims to bridge the gap between traditional pharmaceutical therapy and nutritional support. Headquartered in Mendrisio, the company serves international markets with a commitment to improving patient outcomes through evidence-based metabolic management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutramont.